Jodi Coughlin
About Jodi Coughlin
Jodi Coughlin serves as the Director of Vendor Relationship Management at Deciphera Pharmaceuticals, where she has worked since 2022. With extensive experience in vendor management across various organizations, she has a strong background in clinical trial outsourcing and strategic partnerships.
Current Role at Deciphera Pharmaceuticals
Jodi Coughlin serves as the Director of Vendor Relationship Management at Deciphera Pharmaceuticals, a position she has held since 2022. In this role, she focuses on developing and maintaining strategic partnerships that support clinical trials. Her responsibilities include overseeing vendor management processes and ensuring compliance with industry guidelines.
Previous Experience at TrialSpark
Prior to her current position, Coughlin worked at TrialSpark as the Director of Vendor Management from 2020 to 2021. During her tenure in New York, she was responsible for managing vendor relationships and optimizing vendor performance to enhance clinical trial processes.
Background in Clinical Trial Management
Coughlin has extensive experience in clinical trial management, having worked at EMD Serono, Inc. as a Clinical Trial Outsourcing Manager from 2013 to 2017. She also held the position of Principal Vendor Manager at PRA Health Sciences from 2018 to 2020, where she developed vendor management strategies in line with ICH E6 R2 guidelines.
Educational Qualifications
Coughlin earned her Bachelor of Science in Health Sciences from the Massachusetts College of Pharmacy and Health Sciences, where she studied Physician Assistant Studies from 2002 to 2004. She also holds a Bachelor of Science degree in Biology from Sacred Heart University, which she completed from 1996 to 2000.
Early Career and Skill Development
Coughlin began her career at Veristat as a Contracts and Proposals Developer in 2008. She later worked at ICON plc as a Clinical Proposal Manager from 2010 to 2013. Throughout her career, she has developed strong skills in vendor management and cross-functional communication, contributing to her effectiveness in clinical trial support.